Heart Disease News and Research

Latest Heart Disease News and Research

CHLA ECMO program honored with prestigious Award for Excellence in Life Support

The Extracorporeal Membrane Oxygenation program at Children's Hospital Los Angeles has been honored for the third time with the prestigious Award for Excellence in Life Support by the Extracorporeal Life Support Organization, an international group of health care professionals and scientists who evaluate hospital treatment therapies for patients fighting complex cardiac disease and respiratory failure.

29 Aug 2014

New research identifies five medical conditions that contribute to more North Carolina SUD cases

Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.

29 Aug 2014

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Royal Philips today announced its presence at the European Society of Cardiology Congress 2014, where the company is highlighting the full range of its cardiology solutions serving clinicians and patients across the care continuum from prevention and diagnosis, to treatment, recovery and wellness.

From Philips Healthcare 29 Aug 2014

Wake Forest Baptist Medical Center receives NCORP grant to conduct cancer clinical trials

Wake Forest Baptist Medical Center has received an $18 million, five-year grant from the National Cancer Institute's Community Oncology Research Program to design and conduct community-based, multi-center screening, prevention and control cancer clinical trials.

29 Aug 2014

Specific foods and dietary patterns help prevent, control diabetes

In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are beneficial in preventing and controlling diabetes.

29 Aug 2014

Vaccine for Chagas disease expected to be available within the next three years

The medical development has been tested in animal models, where it was observed that the disease stopped in 80 percent of cases; physicians expect similar results from a human control group.

29 Aug 2014

Viewpoints: Medicare no longer 'busting' the budget; a 'nightmare' trying to get coverage in D.C.

You're looking at the biggest story involving the federal budget and a crucial one for the future of the American economy. Every year for the last six years in a row, the Congressional Budget Office has reduced its estimate for how much the federal government will need to spend on Medicare in coming years.

29 Aug 2014

State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

A heroin crisis gripping communities across the country deepened in New York last year, with more people in the city dying in overdoses from the drug than in any year since 2003. In all, 420 people fatally overdosed on heroin in 2013 out of a total of 782 drug overdoses, rising to a level not seen in a decade in both absolute numbers and as a population-adjusted rate, according to preliminary year-end data from the city's health department (Goodman, 8/28).

29 Aug 2014

School nurses reach 98% of students in U.S. public schools to diagnose primary immunodeficiency

School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).

28 Aug 2014

Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Amgen today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration for evolocumab seeking approval for the treatment of high cholesterol.

28 Aug 2014

Childhood inflammation linked to adult psychosis

Elevated levels of the inflammatory marker interleukin -6 in childhood are associated with an increased risk of psychosis and depression in adulthood, research shows.

28 Aug 2014

Optimal personalised treatment improves bipolar life quality, functioning

Optimal personalised treatment improves quality of life and functioning of patients with bipolar disorder type I or II, suggests research published in the Journal of Affective Disorders.

28 Aug 2014

Aberrant reward processing likely to precede bipolar symptom onset

Healthy children who have a parent with bipolar disorder show altered brain activation during reward processing, research shows.

28 Aug 2014

Risk-based treatment approach should be considered for patients with hypertension

Blood pressure-lowering treatment should target patients at greatest cardiovascular risk and not just those with the highest baseline levels, suggest findings of a meta-analysis.

28 Aug 2014

Lifestyle intervention shows kidney benefits in diabetic patients

A lifestyle intervention focused on weight loss and increasing physical activity should be considered as additional treatment to prevent advanced kidney disease in overweight or obese people with Type 2 diabetes, say researchers.

28 Aug 2014

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

The CAIDE Dementia Risk App from Merz Pharmaceuticals is available free of charge for people from 40 to 65 to calculate their individual risk for getting dementia within the next two decades. Using a traffic light color scheme, the App can also help physicians discuss preventive measures with patients at risk.

28 Aug 2014

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

28 Aug 2014

Armetheon raises $7 million in first round of financing

Armetheon, Inc., a biopharmaceutical company focused on developing novel mid- to late-stage cardiovascular drug candidates, today announced that it has raised $7.0 million in its first round of financing.

28 Aug 2014

First Edition: August 28, 2014

Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending.

28 Aug 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, a serious lung disease that narrows the small blood vessels in the lungs.

28 Aug 2014

Heart Disease News and Research

Latest Heart Disease News and Research

CHLA ECMO program honored with prestigious Award for Excellence in Life Support

New research identifies five medical conditions that contribute to more North Carolina SUD cases

Philips to highlight full range of cardiology solutions at ESC Congress 2014

Wake Forest Baptist Medical Center receives NCORP grant to conduct cancer clinical trials

Specific foods and dietary patterns help prevent, control diabetes

Vaccine for Chagas disease expected to be available within the next three years

Viewpoints: Medicare no longer 'busting' the budget; a 'nightmare' trying to get coverage in D.C.

State highlights: Heroin deaths rise in N.Y.; TennCare computer system delay; Colo. races to win $87M to integrate care;

School nurses reach 98% of students in U.S. public schools to diagnose primary immunodeficiency

Amgen seeks FDA approval for evolocumab to treat patients with high cholesterol

Childhood inflammation linked to adult psychosis

Optimal personalised treatment improves bipolar life quality, functioning

Aberrant reward processing likely to precede bipolar symptom onset

Risk-based treatment approach should be considered for patients with hypertension

Lifestyle intervention shows kidney benefits in diabetic patients

Merz Pharmaceuticals launches new CAIDE Dementia Risk App

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Armetheon raises $7 million in first round of financing

First Edition: August 28, 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in